These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. GP IIB/IIIA blockers with and without thrombolytic agent in prehospital treatment of acute myocardial infarction. Verheugt FW Thromb Res; 2001 Sep; 103 Suppl 1():S113-6. PubMed ID: 11567678 [TBL] [Abstract][Full Text] [Related]
6. Facilitation of thrombolysis in acute myocardial infarction. Gambhir DS Indian Heart J; 1999; 51(5):486-8. PubMed ID: 10721636 [No Abstract] [Full Text] [Related]
7. Glycoprotein IIb/IIIa inhibitors in acute ST segment elevation myocardial infarction. Holper EM; Giugliano RP; Antman EM Coron Artery Dis; 1999 Dec; 10(8):567-73. PubMed ID: 10599535 [TBL] [Abstract][Full Text] [Related]
8. Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials). Rebeiz AG; Johanson P; Green CL; Crater SW; Roe MT; Langer A; Giugliano RP; Lincoff AM; Newby LK; Harrington RA; Topol EJ; Califf RM; Wagner GS; Krucoff MW Am J Cardiol; 2005 Mar; 95(5):611-4. PubMed ID: 15721101 [TBL] [Abstract][Full Text] [Related]
9. The use of glycoprotein IIb/IIIa inhibitor therapy in acute ST-segment elevation myocardial infarction: current practice and future trends. Campbell KR; Ohman EM; Cantor W; Lincoff AM Am J Cardiol; 2000 Apr; 85(8A):32C-8C. PubMed ID: 10793178 [TBL] [Abstract][Full Text] [Related]
10. The use of platelet glycoprotein IIb/IIIa receptor antagonists during the acute phase of myocardial infarction. van den Brand M; Ronner EF Semin Interv Cardiol; 1999 Jun; 4(2):85-8. PubMed ID: 10473877 [No Abstract] [Full Text] [Related]
11. Glycoprotein IIb/IIIa antagonism and fibrinolytic therapy for acute myocardial infarction. Vivekananthan DP; Patel VB; Moliterno DJ J Interv Cardiol; 2002 Apr; 15(2):131-9. PubMed ID: 12063808 [TBL] [Abstract][Full Text] [Related]
12. [Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study]. Franzosi MG Ital Heart J Suppl; 2001 Sep; 2(9):1034-6. PubMed ID: 11675828 [No Abstract] [Full Text] [Related]
13. Administration of glycoprotein IIb-IIIa inhibitors in patients with ST-segment elevation myocardial infarction. Dobesh PP; Kasiar JB Pharmacotherapy; 2002 Jul; 22(7):864-88. PubMed ID: 12126220 [TBL] [Abstract][Full Text] [Related]
15. Relationship between therapeutic time intervals and intermediate term left ventricular systolic function in patients treated with facilitated percutaneous coronary intervention for acute myocardial infarction. Meyborg P; Abdel-Wahab M; Herrmann G; Geist V; Khattab AA; Krüger D; Lins M; Toelg R; Simon R; Richardt G Clin Res Cardiol; 2007 Feb; 96(2):94-102. PubMed ID: 17160565 [TBL] [Abstract][Full Text] [Related]
16. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. Cannon CP; Weintraub WS; Demopoulos LA; Vicari R; Frey MJ; Lakkis N; Neumann FJ; Robertson DH; DeLucca PT; DiBattiste PM; Gibson CM; Braunwald E; N Engl J Med; 2001 Jun; 344(25):1879-87. PubMed ID: 11419424 [TBL] [Abstract][Full Text] [Related]
17. The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect? Brener SJ J Am Coll Cardiol; 2009 May; 53(18):1674-6. PubMed ID: 19406343 [No Abstract] [Full Text] [Related]
19. Glycoprotein IIb/IIIa receptor antagonists in the treatment of acute ST elevation MI: from hypotheses to unexpected recent observations. Ross AM J Thromb Thrombolysis; 2003 Apr; 15(2):85-9. PubMed ID: 14618074 [TBL] [Abstract][Full Text] [Related]
20. Bivalirudin versus heparin plus a glycoprotein IIb/IIIa inhibitor in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention after clopidogrel pretreatment: pooled analysis from the ACUITY and ISAR-REACT 4 trials. Ndrepepa G; Neumann FJ; Deliargyris EN; Mehran R; Mehilli J; Ferenc M; Schulz S; Schömig A; Kastrati A; Stone GW Circ Cardiovasc Interv; 2012 Oct; 5(5):705-12. PubMed ID: 23048052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]